Expressive vocabulary assessment examples
The Patient Health Questionnaire (PHQ-9) for Depression is one of those tools most clinicians have used countless times. It's quick, familiar, and easy to score. And because it's so familiar, I think we sometimes forget to ask what the number is actually telling us.
The Patient Health Questionnaire (PHQ-9) for depression is a nine-item self-report measure of depressive symptoms over the previous two weeks. Each response is scored from 0 to 3, for a total of 0 to 27. It can help us screen for depression and monitor symptoms over time. But it isn't a diagnosis, and it certainly isn't the whole clinical picture.
What does the Patient Health Questionnaire (PHQ-9) for depression measure?
The Patient Health Questionnaire PHQ-9 for depression asks about mood, interest or pleasure, sleep, energy, appetite, self-worth, concentration, psychomotor changes, and thoughts of death or self-harm. It also asks how difficult these problems make everyday functioning.
Two clients can have the same score and be experiencing very different levels of disruption. One may be getting through work but barely functioning at home. Another may have symptoms related to chronic pain, a medical condition, or a major life transition.
The original PHQ-9 validation study found that scores tracked with depression severity and functional impairment. But among depression assessment instruments, no single questionnaire tells us why symptoms are happening. I want to know what's changed in this person's life, what their baseline looks like, and what else might explain their responses.
What are the PHQ-9 scoring interpretation ranges?
The commonly used PHQ-9 scoring interpretation ranges are:
0–4: Minimal symptoms
5–9: Mild symptoms
10–14: Moderate symptoms
15–19: Moderately severe symptoms
20–27: Severe symptoms
These PHQ-9 scoring interpretation ranges describe reported symptom severity, not a confirmed diagnosis. A score of 10 or above is a commonly used screening threshold, but a positive screen requires clinical evaluation.
I think the biggest mistake we can make with PHQ-9 scoring interpretation ranges is allowing the category to become the conclusion. If someone scores a 16, I know their responses fall in the moderately severe range. I don't yet know whether their presentation reflects major depressive disorder, grief, a medical issue, another mental health condition, or several things happening at once.
When reviewing PHQ-9 scoring interpretation ranges, I also look at individual items. Did sleep improve while hopelessness worsened? Did the total score stay the same even though the symptoms most affecting daily life shifted? The pattern can be as clinically useful as the total.
Why does item 9 require follow-up?
Item 9 asks about thoughts of being better off dead or hurting oneself. Any response other than “not at all” necessitates timely clinical follow-up. It does not automatically establish suicidal intent, but it should never be treated as just another point in the total.
I would clarify what the client meant, assess suicidal thoughts and behaviors as indicated, and consider intent, planning, access to means, protective factors, and the appropriate level of care. Even a zero on item 9 doesn't rule out suicide risk when other clinical information raises concern.
Research on PHQ-9 item 9 supports taking endorsements seriously because the item catches most clients at risk, but it also flags many who aren't, so it shouldn't serve as a standalone risk indicator.
This is one reason the Patient Health Questionnaire (PHQ-9) for depression should support, rather than replace, a comprehensive assessment. A screening response starts a conversation and supports clinical judgment but it doesn’t replace it.
How does PHQ-9 vs. PHQ-2 screening work?
With PHQ-9 vs. PHQ-2 screening, the main difference is how much information we're collecting. The PHQ-2 uses the first two questions—depressed mood and loss of interest or pleasure—as a brief initial screen. The PHQ-9 covers a broader range of symptoms and supports severity monitoring.
PHQ-9 vs. PHQ-2 screening isn't necessarily an either-or choice. A practice may use the PHQ-2 first, then follow a positive result with the PHQ-9 and appropriate clinical assessment. Which approach makes sense depends on the setting, population, and reason for screening.
The original PHQ-2 validation study supports its use as a brief depression screener. Like other depression assessment instruments, both tools help identify what deserves further attention. Neither the Patient Health Questionnaire (PHQ-9) for depression nor the PHQ-2 screenings independently establish a diagnosis.
How can the PHQ-9 support measurement-based care outcome tracking?
This is where I think the Patient Health Questionnaire PHQ-9 for depression becomes especially valuable. Measurement-based care outcome tracking means collecting standardized information at clinically meaningful intervals and using it to inform treatment conversations.
Imagine a client tells me, “I don't think therapy is helping,” but their PHQ-9 score has dropped from 21 to 12. I wouldn't respond, “Well, the numbers say you're better.” I'd be curious. Maybe their energy and sleep improved, but their relationships still feel just as painful. Maybe they've made meaningful progress that they haven't quite recognized yet.
The reverse matters too. Someone may report feeling better while their PHQ-9 score increases. That's information worth exploring, not proof that their account is wrong.
Good measurement-based care outcome tracking creates opportunities for collaborative clinical judgment. We can compare scores, examine the individual symptoms, and ask whether our treatment approach is addressing what matters most to the client.
For the Patient Health Questionnaire PHQ-9 for depression, consistency helps: use the same measure over time, review changes with the client, and document how the findings inform care. A number without a conversation is a missed opportunity.
What should clinicians know about PHQ-9 CPT code 96127 billing?
PHQ-9 CPT code 96127 billing comes up frequently because CPT 96127 describes brief emotional or behavioral assessment, with scoring and documentation, using a standardized instrument.
But PHQ-9 CPT code 96127 billing isn't automatic just because a client completed the questionnaire. Reimbursement depends on the payer, clinician eligibility, setting, documentation, frequency limits, and whether the service is separately payable or bundled with another service.
Before billing PHQ-9 CPT code 96127, check current payer guidance and applicable coding requirements. A clinically useful tool and a separately reimbursable service aren't always the same thing.
How should clinicians interpret PHQ-9 results in practice?
I come back to the same question every time: What does this PHQ-9 result mean for this particular client?
The Patient Health Questionnaire PHQ-9 for depression gives us a shared starting point. The PHQ-9 scoring interpretation ranges help us describe severity. Measurement-based care outcome tracking helps us notice change. And the individual responses can point us toward questions we might otherwise overlook.
But the Patient Health Questionnaire PHQ-9 for depression doesn't know the client's history, relationships, medical context, or what it took for them to walk into our office that day.
That's our job. Use the data, stay curious about the discrepancies, and let the measure inform the clinical conversation rather than replace it.
Sources
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine.
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003). The Patient Health Questionnaire-2: Validity of a two-item depression screener. Medical Care.
Na, P. J., Yaramala, S. R., Kim, J. A., Kim, H., Goes, F. S., et al. (2018). The PHQ-9 item 9 based screening for suicide risk: A validation study of the Patient Health Questionnaire (PHQ)-9 item 9 with the Columbia Suicide Severity Rating Scale (C-SSRS). Journal of Affective Disorders.
Negeri, Z. F., Levis, B., Sun, Y., He, C., Krishnan, A., et al. (2021). Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: Updated systematic review and individual participant data meta-analysis. BMJ.
U.S. Preventive Services Task Force. (2023). Depression and suicide risk in adults: Screening.
How SimplePractice streamlines running your practice
SimplePractice is HIPAA-compliant practice management software with everything you need to run your practice built into the platform—from booking and scheduling to insurance and client billing.
If you’ve been considering switching to an EHR system, SimplePractice empowers you to run a fully paperless practice—so you get more time for the things that matter most to you.
Try SimplePractice free for 30 days. No credit card required.
